Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives
US6211177A · kind A · utility
45Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 1998 |
| Grant date | Apr 3, 2001 |
| Priority date | — |
| Expiry date | Nov 24, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions, by exposing the affected cells to substituted 2-aryl-benzimidazoles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.